876391-67-2

Upstream product

• 13423-48-8 triphenylheptylphosphonium bromide 
• 1122-91-4 4-bromo-benzaldehyde 
• 111-66-0 oct-1-ene 

Downstream Products

• 49763-66-8 4-octylbenzaldehyde 
• 1265287-04-4 C₇₇H₉₀CuN₄O 
• 866957-68-8 copper(II) tetra(p-octylphenyl)porphyrin 
• 876391-73-0 phosphoric acid di-tert-butyl ester 4-[2-(4-octyl-phenyl)-ethyl]-2-trichloromethyl-4,5-dihydro-oxazol-4-ylmethyl ester 
• 876391-75-2 {(R)-4-[2-(4-Octyl-phenyl)-ethyl]-2-trichloromethyl-4,5-dihydro-oxazol-4-yl}-methanol 
• 876391-72-9 (2S)-2-(2'-(trichloromethyl)-4',5'-dihydrooxazol-5-yl)-4-(4''-octylphenyl)-butan-1-ol 
• 876391-74-1 (2R)-2-(oxiranyl)-4-(4'-octylphenyl)butan-1-ol 
• 876391-70-7 (2S)-2-(oxiranyl)-4-(4'-octylphenyl)butan-1-ol 
• 876391-69-4 2-methylene-4-(4'-octylphenyl)butan-1-ol 
• 876391-68-3 2-methylene-4-(4'-octylphenyl)butanal 
• 402616-26-6 (S)-fingolimod phosphate 
• 402616-23-3 FTY 520P 
• 183129-84-2 4-(4'-n-octylphenyl)butan-1-ol 

Relevant academic research and scientific papers

Enantioselective synthesis of the phosphate esters of the immunosuppressive lipid FTY720

The enantiomers of FTY720-phosphate (3) were synthesized via 2-methylene-4-(4-octylphenyl)butan-1-ol (7), 2,3-epoxy alcohol 8, and Δ2-oxazoline 10. These compounds have potential use in the treatment of autoimmune diseases and prevention of kid

Synthesis and characterization of π-extended porphyrins as potential precursors for the formation of columnar mesophases: Design principles for columnar mesophases need revision?

A series of meso-a bridged extended porphyrins substituted with long aliphatic chains were synthesized and fully characterized. Two different synthetic strategies were tested to obtain the target structures. The synthetic steps were optimized in order to obtain scalable routes for the production of sufficient quantities of η-extended porphyrins for material science studies. The porphyrins were obtained either as free bases or complexed with Ni II or CuII. UV-Vis spectroscopy and polarized light microscopy was used for the analysis of the material properties of the η-extended porphyrins. The results obtained with our compounds are not compatible with the results reported in the literature. ARKAT-USA, Inc.